These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32100354)

  • 1. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.
    Laitakari A; Huttunen R; Kuvaja P; Hannuksela P; Szabo Z; Heikkilä M; Kerkelä R; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    FASEB J; 2020 Apr; 34(4):5590-5609. PubMed ID: 32100354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.
    Laitakari A; Ollonen T; Kietzmann T; Walkinshaw G; Mennerich D; Izzi V; Haapasaari KM; Myllyharju J; Serpi R; Dimova EY; Koivunen P
    Redox Biol; 2019 Apr; 22():101145. PubMed ID: 30802717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
    Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.
    Hyvärinen J; Hassinen IE; Sormunen R; Mäki JM; Kivirikko KI; Koivunen P; Myllyharju J
    J Biol Chem; 2010 Apr; 285(18):13646-57. PubMed ID: 20185832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
    Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of P4H-TM in mice results in age-related retinal and renal alterations.
    Leinonen H; Rossi M; Salo AM; Tiainen P; Hyvärinen J; Pitkänen M; Sormunen R; Miinalainen I; Zhang C; Soininen R; Kivirikko KI; Koskelainen A; Tanila H; Myllyharju J; Koivunen P
    Hum Mol Genet; 2016 Sep; 25(17):3810-3823. PubMed ID: 27466183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.
    Kerkelä R; Karsikas S; Szabo Z; Serpi R; Magga J; Gao E; Alitalo K; Anisimov A; Sormunen R; Pietilä I; Vainio L; Koch WJ; Kivirikko KI; Myllyharju J; Koivunen P
    Mol Cell Biol; 2013 Aug; 33(16):3321-9. PubMed ID: 23775121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation.
    Byts N; Sharma S; Malm T; Kaakinen M; Korhonen P; Jaakkonen L; Keuters M; Huuskonen M; Pietilä I; Koistinaho J; Koivunen P; Myllyharju J
    J Biol Chem; 2022 Mar; 298(3):101721. PubMed ID: 35151685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Mäkinen S; Sree S; Ala-Nisula T; Kultalahti H; Koivunen P; Koistinen HA
    Diabetologia; 2024 Sep; 67(9):1943-1954. PubMed ID: 38814443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the hypoxia response pathway protects against age-induced cardiac hypertrophy.
    Röning T; Magga J; Laitakari A; Halmetoja R; Tapio J; Dimova EY; Szabo Z; Rahtu-Korpela L; Kemppi A; Walkinshaw G; Myllyharju J; Kerkelä R; Koivunen P; Serpi R
    J Mol Cell Cardiol; 2022 Mar; 164():148-155. PubMed ID: 34919895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways.
    Ullah K; Rosendahl AH; Izzi V; Bergmann U; Pihlajaniemi T; Mäki JM; Myllyharju J
    Sci Rep; 2017 Dec; 7(1):17220. PubMed ID: 29222481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.
    Leinonen H; Koivisto H; Lipponen HR; Matilainen A; Salo AM; Dimova EY; Hämäläinen E; Stavén S; Miettinen P; Myllyharju J; Koivunen P; Tanila H
    Neuropharmacology; 2019 Jul; 153():63-72. PubMed ID: 31029587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia.
    Rosendahl AH; Monnius M; Laitala A; Railo A; Miinalainen I; Heljasvaara R; Mäki JM; Myllyharju J
    J Biol Chem; 2022 Apr; 298(4):101787. PubMed ID: 35247391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.